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Abstract   1 
Promyelocytic leukemia (PML) proteins form the basis of PML nuclear bodies (NBs), which control 2 
many important processes. We screened an shRNA library targeting ubiquitin pathway proteins for 3 
effects on PML NBs and identified RNF8 and RNF168 DNA damage response proteins as negative 4 
regulators of PML NBs. Additional studies confirmed that depletion of either RNF8 or RNF168 5 
increased the level of PML NBs and proteins, while overexpression induced loss of PML NBs. 6 
RNF168 partially localized to PML NBs through its UMI/MIU1 ubiquitin interacting region and 7 
associated with NBs formed by any PML isoform. The association of RNF168 with PML NBs resulted 8 
in increased ubiquitylation and SUMO2 modification of PML proteins. In addition, RNF168 was 9 
found to associate with SUMO2/3 modified proteins in a manner dependent on its ubiquitin binding 10 
sequences, suggesting that hybrid SUMO-ubiquitin chains might be bound. In vitro assays confirmed 11 
that RNF168 preferentially binds hybrid SUMO2-K63 ubiquitin chains over individual SUMO2 or 12 
K63 ubiquitin chains. Our study identified previously unrecognized roles for RNF8 and RNF168 in 13 




             Promyelocytic leukemia (PML) nuclear bodies (NBs) are discreet foci in mammalian cells 18 
formed on the basis of PML proteins. PML proteins were so named because a translocation resulting 19 
in a PML-retinoic acid receptor alpha (RARα) fusion protein  results in the development of acute 20 
promyelocytic leukemia (APL) (Salomoni et al. 2008). Considerable evidence now indicates that PML 21 
proteins and NBs are tumour suppressors in general and that increasing PML levels is an effective way 22 
of inhibiting the growth of tumour cells (Scaglioni et al. 2006; Wu et al. 2014; Salomoni et al. 2008). 23 
The tumour-suppressing properties of PML NBs stems from their important contributions to multiple 24 
cellular processes including apoptosis, p53 activation, DNA repair and senescence (Salomoni et al. 25 
2008; Lallemand-Breitenbach and de The 2010; Nisole et al. 2013).  26 
PML NBs contain six different nuclear PML isoforms (PML I to VI) that are derived from 27 
alternative splicing events in the C-terminal portion of the protein, and there is evidence that specific 28 
PML isoforms mediate distinct functions associated with the NBs (Bernardi and Pandolfi 2007; 29 
Condemine et al. 2006; Nisole et al. 2013). PML proteins contain a SUMO interacting motif (SIM) 30 
and multiple SUMO-modified sites that mediate interactions between the PML proteins allowing for 31 
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the formation of the NB (Bernardi and Pandolfi 2007; Shen et al. 2006b).  In addition to PML proteins, 32 
the NBs contain many other proteins that vary in their dynamics of association and mediate the various 33 
NB functions. Many proteins (eg. Daxx) associate with PML NBs through SUMO-SIM interactions 34 
with PML core sequences, while others (eg. p53) associate with the C-terminal tail sequences specific 35 
to a particular isoform (Bernardi and Pandolfi 2007; Nisole et al. 2013).   36 
In addition to their cellular roles, PML NBs are part of the innate immune response that 37 
suppresses infection by several viruses  (Geoffroy and Chelbi-Alix 2011; Everett and Chelbi-Alix 38 
2007; Nisole et al. 2013; Tavalai and Stamminger 2011; Sivachandran et al. 2012b).  To overcome 39 
PML suppression, these viruses encode proteins that disrupt PML NBs by a variety of mechanisms 40 
that include inducing degradation of PML proteins, interfering with PML protein interactions by 41 
inhibiting SUMOylation, and restructuring of PML NBs into tracts (Tavalai and Stamminger 2009; 42 
Nisole et al. 2013; Geoffroy and Chelbi-Alix 2011; Everett and Chelbi-Alix 2007; Sivachandran et al. 43 
2008). These studies showed that PML NB functions can be regulated by manipulating PML proteins 44 
and provided a framework for studies on cellular regulation of PML NBs.  In addition, considerable 45 
information on the regulation of PML NBs has come from studying how they are affected by arsenic 46 
trioxide, a treatment for APL that induces the loss of NBs formed by PML-RARα fusion proteins, 47 
allowing restoration of NBs formed by the nonmutated copy of PML (Ablain et al. 2014; de The et al. 48 
2012). Arsenic induces hyper-SUMOylation of PML proteins, resulting in recruitment of the SUMO-49 
targeted E3 ligases RNF4 and Arkadia (Erker et al. 2013; Lallemand-Breitenbach et al. 2008; Tatham 50 
et al. 2008). RNF4 in particular has been shown to be important for the arsenic-induced PML 51 
degradation (Lallemand-Breitenbach et al. 2008; Tatham et al. 2008).  52 
Under normal cell growth conditions, the level of PML proteins also appears to be largely 53 
regulated by ubiquitylation and proteasomal-mediated degradation (Rabellino and Scaglioni 2013).  54 
PML proteins contain a phosphodegron that, upon phosphorylation by casein kinase 2 (CK2), triggers 55 
polyubiquitylation (Scaglioni et al. 2006; Scaglioni et al. 2008).  However the E3 ligase responsible 56 
for this ubiquitylation has not been identified. A few ubiquitin E3 ligases have been reported to 57 
promote PML loss under specific circumstances. For example, the KLHL20-Cul3-ROC1 complex 58 
down-regulates PML in response to hypoxia (Yuan et al. 2011) and SIAH1 and SIAH2 can induce 59 
PML degradation upon overexpression (Fanelli et al. 2004). In addition, E6AP has been identified as a 60 
PML regulator in Burkitt’s lymphoma (Wolyniec et al. 2012). The ubiquitin specific protease USP7 61 
has also been shown to negatively regulate PML NBs in nasopharyngeal carcinoma cells, by 62 
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promoting the degradation of PML proteins in a manner independent of its catalytic activity (Sarkari et 63 
al. 2011; Sivachandran et al. 2008). Despite these specific studies, there is still much to be learned 64 
about which ubiquitin pathway proteins regulate the levels of PML proteins and NBs.  65 
To gain a more comprehensive understanding of cellular ubiquitin pathway proteins that 66 
regulate PML NBs, we screened an shRNA library targeting ~500 ubiquitin pathway proteins for 67 
effects on PML NBs. The screen identified RNF8 and RNF168, known to work together in DNA 68 
repair, as E3 ubiquitin ligases whose depletion increases the number and intensity of PML NBs. 69 
Additional studies confirmed that silencing of RNF8 or 168 increased PML NBs and protein levels, 70 
while overexpression of either protein induced loss of PML NBs. RNF168 was further shown to 71 
localize to PML NBs through the UMI/MIU1 sequence in a PML isoform-independent manner, and to 72 
bind to hybrid SUMO2-ubiquitin chains. The results suggest additional roles for RNF8 and 168 in 73 
PML regulation.  74 
 75 
RESULTS 76 
Identification of RNF8 and RNF168 as PML regulators 77 
We have previously identified a mechanism by which an Epstein-Barr virus (EBV) protein, 78 
EBNA1, induces loss of PML NBs and degradation proteins in nasopharyngeal carcinoma (NPC) and 79 
gastric carcinoma, two EBV-associated cancers (Sivachandran et al. 2012a; Sivachandran et al. 2008; 80 
Sivachandran et al. 2010).  However, little is known about the cellular ubiquitin pathway proteins that 81 
regulate PML proteins in these cells.  To identify cellular ubiquitin pathway proteins that regulate 82 
PML NBs in NPC cells, we conducted a high-content screen in which ~2500 lentiviruses expressing 83 
shRNAs designed to silence ~500 ubiquitin pathway proteins (E1s, E2s, E3s and deubiquitylating 84 
proteins) were used to infect the NPC cell line CNE2Z in triplicate. Several days later, cells were 85 
stained for PML and imaged by confocal microscopy and the number and intensity of PML NBs was 86 
determined.  Target proteins in which two or more of the five shRNAs increased the average PML NB 87 
number 1.5 fold or more or increased average PML NB intensity 2-fold or more were considered for 88 
further study.  The E3 ligases RNF8 and RNF168, which are known to work together to repair double 89 
stranded DNA breaks (Al-Hakim et al. 2010), met these criteria. As shown in Figure 1, multiple 90 
shRNAs targeting RNF8 or RNF168 increased the number and/or intensity of PML NBs relative to 91 
uninfected cells and also to a negative control lentivirus expressing shRNA targeting RNF111. The 92 
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latter lentivirus serves as a negative control for lentivirus infection, because RNF111 expression levels 93 
are already undetectable in these cells (data not shown).     94 
The effect of RNF8 and RNF168 on PML NBs was further examined, first by depleting these 95 
proteins with siRNA. siRNA-mediated depletion  of either protein resulted in an obvious increase in 96 
the number and intensity of the PML NBs (Fig. 2A and B).  In keeping with these results, Western 97 
blots showed that the total level of PML proteins was increased upon silencing RNF8 or RNF168 (Fig. 98 
2C). siRNA-mediated depletion of RNF8 or RNF168 also increased the levels of PML NBs and 99 
proteins in U2OS cells, showing that the effects are not cell line specific (Fig. 2D to F). Conversely, 100 
overexpression of FLAG-tagged RNF8 or RNF168 decreased the number of PML NBs (Fig. 3).   101 
 102 
RNF168 can modulate PML NBs independently from RNF8 103 
In response to DNA damage, RNF8 is recruited to sites of double-stranded DNA breaks 104 
(DSBs) where it ubiquitylates histones H2A/H2AX, which results in recruitment of RNF168.  105 
Therefore the role of RNF168 in the DNA damage response (DDR) depends on RNF8.  We asked 106 
whether a similar relationship exists for the roles of RNF8 and RNF168 in regulating PML NBs. To 107 
this end, we treated CNE2Z cells with siRNA targeting RNF8 or negative control siRNA, then 108 
transfected them with a plasmid expressing FLAG-RNF168 (to overexpress RNF168) or an empty 109 
plasmid (pcDNA3).  Cells were then stained for FLAG and PML and the number of PML NBs in 110 
FLAG-positive cells were compared to the empty plasmid control (Fig.4).  As expected, RNF8 111 
silencing (which was confirmed by Western blotting; Fig 4B) in the presence of pcDNA3 resulted in a 112 
notable increase in PML NBs (from 11 to 16 on average; Fig. 4A and C).  Also as expected, in control 113 
siRNA samples, RNF168 overexpression notably decreased the number of PML NBs relative to the 114 
pcDNA3 control (from 11 to 6 on average; Fig. 4A and C).  However, RNF168 overexpression was 115 
also found to induce the loss of PML NBs in RNF8-silenced samples (from 16 to 9 on average; Fig. 116 
4A and C).  The results indicate that RNF168 is able to induce PML loss in the absence of RNF8, at 117 
least under conditions of RNF168 overexpression. For completeness, we also did the opposite 118 
experiment, in which the ability of overexpressed RNF8 to induce PML NB loss was tested with and 119 
without RNF168 silencing (Fig. S1).  RNF8 retained the ability to induce loss of PML NBs after 120 
RNF168 depletion, indicating the RFN8 and RNF168 can work independently of each other. We 121 




Localization of RNF168 to PML NBs 124 
To gain insight into whether RNF168 was acting directly at PML NBs, we asked whether 125 
RNF168 localized to PML NBs.  To this end, FLAG-tagged RNF168 with and without deletions of 126 
previously characterized functional elements were expressed in CNE2Z cells, followed by staining 127 
for FLAG and PML (Fig. 5A and B). As previously reported, overexpression of WT RNF168 results 128 
in the formation of aggregates interfering with assessment of nuclear localization (Pinato et al. 129 
2009). This aggregation is not seen with RNF168 mutants lacking the RING domain (ΔRING) or 130 
MIU2 ubiquitin-binding sequence (ΔMIU2). Both of these proteins showed nuclear diffuse staining 131 
with some foci that localize to the PML NBs (Fig. 5B). The localization to PML NBs was not an 132 
artifact of overexpression, as ΔRING localized to PML NBs even at very early post-transfection 133 
times, when ΔRING expression levels were close to those of endogenous RNF168 (Fig. S2A). The 134 
localization to PML NBs was not particular to CNE2Z cells, as ΔMIU2 was also found to form foci 135 
in U2OS cells, some of which coincide with PML NBs (Fig. S2B). The localization to PML NBs 136 
was abrogated when the UMI and MIU1 ubiquitin-binding sequences were deleted individually or 137 
together within the context of ΔMIU2 (compare ΔMIU2 to Δ100-201ΔMIU2, ΔMIU1ΔMIU2 or 138 
ΔUMIΔMIU2 in Fig 5B), implicating the UMI/MIU1 region as a PML-targeting sequence. While 139 
the expression level of the different mutants examined for PML localization varied considerably 140 
(Fig. 5C), there was no correlation between PML NB localization and expression level. The ability 141 
of the UMI/MIU1 region to interact with PML NBs was further examined by expressing an RNF168 142 
fragment containing amino acids 100-201 fused to GFP (Fig. 5C and D).  GFP-100-201 formed 143 
prominent foci that localized to PML NBs, whereas no such foci were seen with the expression of 144 
GFP alone (Fig. 5D). In addition, removal of MIU1 from this construct (GFP-100-166) resulted in 145 
the loss of prominent PML-localizing foci, confirming that MIU1 plays a role in recruitment to PML 146 
NBs.  147 
Since RNF168 is known to have a role in the DNA damage response (DDR) involving its 148 
recruitment to DNA repair sites, we examined whether RNF168 can also associate with PML NBs 149 
during the DNA damage response. To this end, FLAG-ΔRING was expressed in CNE2Z cells, 150 
which were then treated with etoposide to induce the DDR (as evidenced by 53BP1 foci formation; 151 
Fig. 5E top panels), followed by staining for FLAG and PML. As shown in Fig. 5E, ΔRING was still 152 
detected at PML NBs, indicating that RNF168 retains its ability to associate with PML NBs during 153 
the DDR. This result is similar to studies on the localization of the Bloom (BLM) DDR protein, 154 
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which localizes with PML NBs both before and after induction of DNA damage (Bischof et al. 155 
2001).  156 
 PML NBs contain 6 different PML isoforms that vary in the length and sequence of their C-157 
terminal regions. Some proteins associate with PML NBs through isoform-specific sequences while 158 
others associate with the conserved PML core sequence. To determine if a specific PML isoform 159 
was responsible for RNF168 recruitment to PML NBs, we examined the localization of RNF168 160 
ΔMIU2 in CNE2Z cells that express single PML isoforms. These cells were previously generated by 161 
silencing total PML with lentivirus-delivered shRNA, then adding back a silencing-resistant PML 162 
isoform with a second lentivirus (Sarkari et al. 2011; Cuchet et al. 2011).  Each PML isoform forms 163 
NBs and this system has been previously used to reveal isoform specificities of some viral and 164 
cellular proteins (Sarkari et al. 2011; Sivachandran et al. 2012b; Cuchet-Lourenco et al. 2012). 165 
Examination of the localization of RNF168 ΔMIU2 in cells with single PML isoforms, revealed that 166 
this protein can localize to NBs formed by any PML isoform, indicating that the interaction is not 167 
through the PML C-terminal tails (Fig 6).  168 
 169 
RNF168 increases PML ubiquitylation and SUMOylation 170 
The loss of PML NBs can result from either polyubiquitylation and degradation of PML 171 
proteins, or from interference with SUMOylation of PML proteins, which interferes with the ability 172 
of the PML proteins to interact to form NBs.  Therefore we examined the effect of RNF168 173 
overexpression on the ubiquitylation and SUMOylation of PML proteins (Fig. 7).  To this end, 174 
CNE2Z cells were co-transfected with a plasmid expressing HA-tagged ubiquitin and a second 175 
plasmid expressing FLAG-tagged RNF168, an RNF168 mutant or empty plasmid, then treated with 176 
proteasomal inhibitor (MG132) to inhibit degradation of the ubiquitylated proteins. PML proteins 177 
were immunoprecipated (IP) with antibody recognizing all PML isoforms under denaturing 178 
conditions, then immuno-blotted for PML and HA (Fig. 7A). Both full-length and ΔMIU2 versions 179 
of RNF168 were found to induce the accumulation of polyubiquitylated forms of PML, whereas an 180 
RNF168 mutant lacking all 3 ubiquitin interacting motifs (ΔUMIΔMIU1ΔMIU2 called ΔUb) 181 
resembled the empty plasmid negative control. Therefore the sequences that are necessary for 182 
RNF168 to associate with PML NBs are also needed for RNF168 to induce PML ubiquitylation. An 183 
RNF168 mutant lacking the catalytic RING domain (ΔRING) was also tested for the induction of 184 
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PML ubiquitylation and found to be impaired relative to RNF168 or ΔMIU2.  However the very low 185 
expression level of this mutant relative to other RNF168 proteins makes the result inconclusive. 186 
To further examine the nature of the ubiquitin modifications of PML that are induced by 187 
RNF168, we repeated the above experiment in the presence and absence of MG132 and, in addition 188 
to detecting total ubiquitin (HA blot), we also blotted with antibodies specific for K48- and K63-189 
linked ubiquitin chains (Fig. 7B). As expected, MG132 treatment resulted in increased levels of total 190 
ubiquitylated products (HA blot; input lanes) and K48-linked ubiquitin products (K48 blot; input 191 
lanes).  In addition, a smaller increase in K63-linked ubiquitin products (K63 blot; input lanes) was 192 
detected in the presence of MG132, consistent with reports that hybrid chains containing SUMO2 193 
and K63 ubiquitin can trigger proteasomal degradation (Tatham et al. 2011).  Consistent with the 194 
known role of RNF168 in synthesizing K63 ubiquitin chains, total levels of these chains (in input 195 
lanes) were increased when RNF168 was overexpressed (relative to the pcDNA3 control lane). PML 196 
IP experiments showed induction of PML ubiquitylation (detected in HA blot) by RNF168 and 197 
ΔMIU2 (relative to the control lane) only when proteasomal degradation was blocked, consistent 198 
with a role of this ubiquitylation in PML degradation.  Immunoprecipitated PML showed some 199 
reactivity with both K48 and K63 ubiquitin antibodies under all conditions, but RNF168 and ΔMIU2  200 
were only found to increase levels of K48 ubiquitin (and to a lesser degree, K63 ubiquitin) on PML 201 
(compared to control lanes) when the proteasome was blocked. Together the results suggest that 202 
RNF168 can increase the levels of both K48 and K63 ubiquitin chains on PML. 203 
 PML proteins are modified by the addition of SUMO1, SUMO2 and SUMO3. These 204 
modifications are needed for nuclear body formation, while hyper-SUMOylation can be a step in 205 
PML degradation (as induced by arsenic trioxide). We examined the effect of RNF168 206 
overexpression on PML SUMOylation by co-transfecting CNE2Z cells with a plasmid expressing 207 
myc-tagged SUMO2 and the indicated FLAG-tagged RNF168 protein or empty plasmid, followed 208 
by IP of total PML (Fig. 7C).  Relative to the empty plasmid negative control, RNF168 was 209 
consistently found to increase the levels of SUMO2-modified PML proteins, whereas ΔUb 210 
(ΔUMIΔMIU1ΔMIU2) did not exhibit this effect and ΔMIU2 and ΔRING  had an intermediate 211 
effect. The results suggest that RNF168-induced loss of PML NBs is not due to interference with 212 
PML SUMOylation, but rather that RNF168 can increase PML SUMOylation.  In addition, the fact 213 
that the low-expressing ΔRING still induced PML SUMOylation to some degree, suggests that the 214 




RNF168 associates with hybrid SUMO2-ubiquitin chains 217 
 The findings that RNF168 associated with PML core sequences, which are known to be 218 
SUMOylated, and could increase SUMOylation of PML proteins prompted us to further examine the 219 
ability of RNF168 to bind SUMO.  To this end, CNE2Z cells were co-transfected with a plasmid 220 
expressing myc-tagged SUMO1, SUMO2 or SUMO3 and a plasmid expressing FLAG-tagged 221 
RNF168 or ΔUb (ΔUMIΔMIU1ΔMIU2) or empty plasmid. FLAG-RNF168 was recovered by IP and 222 
recovery of Myc-SUMO examined by Western blots (Fig. 8A). Consistent with previous reports, 223 
input lanes showed that SUMO2 and SUMO3 formed high molecular weight chains more efficiently 224 
than SUMO1.  In addition, an increase in the total level of SUMO2 or SUMO3 chains was 225 
consistently seen in the presence of RNF168 relative to the empty plasmid control (compare lane 2 226 
to lane 5 and lane 3 to lane 6).  FLAG IPs showed that full length RNF168 associates with the 227 
SUMO2 and SUMO3 chains (compare lanes 11 and 12 to lanes 14 and 15), and that this interaction 228 
is greatly decreased by deletion of the three ubiquitin interacting regions in the ΔUb mutant (lanes 17 229 
and 18).  We did not detect any shifted forms of FLAG-RNF168 in either the input or FLAG-IP 230 
samples (see FLAG blots), suggesting that RNF168 itself is not SUMO-modified, but rather can bind 231 
to SUMO2/3 chains.  However, a direct interaction between purified RNF168 and free SUMO2 or 232 
SUMO3 chains was not detected in in vitro binding assays (data not shown).  This suggests that 233 
RNF168 is not simply recognizing SUMO2/3 but rather SUMO2/3 in a particular context. 234 
 Hybrid SUMO-ubiquitin chains have been described consisting of a SUMO2 chain joined 235 
to a K63-linked ubiquitin chain (Tatham et al. 2013), and these can be specifically recognized by 236 
some proteins (Geoffroy and Hay 2009; Guzzo et al. 2012; Hu et al. 2012). The UMI/MUI1 237 
sequences of RNF168 that we found to be important for recovery of SUMO2 chains have been 238 
previously shown to recognize K63-linked ubiquitin (Panier et al. 2012), raising the possibility 239 
that the SUMO2-containing material that we recovered are hybrid SUMO-ubiquitin chains. To 240 
investigate this possibility, affinity resins were generated that contain one of the following: K63-241 
ubiquitin polymers (K63-Ub), linear 4xSUMO2 chains (4xSUMO-2), N-terminally 242 
monoubiquitinated 4xSUMO2 chains (Ub-4xSUMO2) or hybrid chains containing K63-ubiquitin 243 
polymers linked to 4xSUMO2 (K63Ub-4xSUMO2) (see Fig. S3A).  Nuclear extracts from 293 244 
cells were incubated with each of these resins as well as with empty resin (blank), and proteins 245 
retained on each resin were identified and quantified by mass spectrometry-based label-free 246 
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quantitative proteomics (Fig. S3B). Ratios of the recovery of each protein on a particular 247 
SUMO/ubiquitin resin relative to the blank resin were then determined (Fig. S3C and D). 248 
RNF168 was one of the highest scoring proteins with much higher recovery on resins containing 249 
K63Ub-SUMO2 hybrid chains than any of the other resins (Figs. 8B, S3C and S3D).  250 
To determine whether RNF168 binds directly to the hybrid chains, assays with the above 251 
affinity resins were repeated using purified RNF168 generated in E.coli, and eluted proteins were 252 
analysed by SDS-PAGE and Coomassie staining. As shown in Fig. 8C, RNF168 was recovered 253 
most efficiently on the resin containing the hybrid K63Ub-4xSUMO2 chains. Consistent with 254 
previous reports (Panier et al. 2012), some binding was also detected to resin containing K63-255 
linked polyubiquitin. The results indicate that the association of RNF168 with SUMO2 chains 256 
involves direct binding to hybrid SUMO2-ubiquitin chains.  257 
 258 
   DISCUSSION 259 
Our screen for proteins that regulate the level of PML NBs identified RNF8 and RNF168 as 260 
proteins whose depletion results in increased number and intensity of PML NBs and increased level 261 
of PML proteins. Conversely overexpression of RNF8 or RNF168 can lead to loss of PML NBs. To 262 
date, RNF8 and RNF168 are known for their important roles in the DDR to double stranded DNA 263 
breaks (Bartocci and Denchi 2013; Al-Hakim et al. 2010). K63-linked ubiquitylation of histones 264 
H2A/H2AX and/or other proteins by RNF8 at DSBs results in the recruitment of RNF168, which 265 
interacts with the ubiquitylated histones through its three ubiquitin-binding motifs (UMI, MIU1, and 266 
MIU2) (Stewart et al. 2009; Bartocci and Denchi 2013; Panier and Durocher 2009; Panier et al. 267 
2012; Mailand et al. 2007; Doil et al. 2009). Further ubiquitylation of H2A/H2AX by RNF168 and 268 
RNF8 then leads to recruitment of additional DNA repair proteins including 53BP1 and BRCA1. 269 
Our current studies indicate additional roles for RNF8 and RNF168 as negative regulators of PML 270 
NBs. 271 
Our studies show that RNF8 and RNF168 can down-regulate PML NBs and proteins.  We 272 
focused subsequent studies on RNF168 due to its partial co-localization with PML NBs, which 273 
suggests it is acting directly on the PML NBs.  Overexpression of full length RNF168 is known to 274 
aggregate in cells and hence is not typically used for functional studies (Pinato et al. 2009). However 275 
deletion of MIU2 or the RING domain abrogates this aggregation and reveals prominent foci that 276 
correspond to PML NBs.  Analyses of additional deletion mutants and GFP-fusion proteins 277 
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identified the UMI/MIU1 region as important for PML targeting.  Since all of our UMI/ MIU1 278 
deletion constructs lacked MIU2, we do not know whether PML targeting is unique to UMI/MIU1 or 279 
can also be mediated by MIU2.   280 
The mechanism by which RNF168 induces PML NB loss appears to involve ubiquitylation 281 
of PML proteins, since overexpression of RNF168 or ΔMIU2 resulted in increased levels of 282 
ubiquitylated PML proteins.  The effect on PML ubiquitylation also fits with the increase in PML 283 
protein levels that were observed upon RNF168 depletion. Induction of PML ubiquitylation requires 284 
UMI/MIU1 PML-targeting sequences in RNF168 (that were deleted in the ΔUb mutant in Fig. 7), 285 
consistent with a requirement to associate with the PML NB to induce PML degradation.  It remains 286 
unclear whether PML is ubiquitylated directly by RNF168, although this is the simplest 287 
interpretation. Interestingly, Tikoo et al (Tikoo et al. 2013) previously found that RNF8 could 288 
conjugate K63-linked ubiquitin to PML proteins in vitro, although this led to an increase rather than 289 
a loss of PML NBs in their system.  We also observed that RNF168 but not the ΔUb mutant 290 
increased the level of SUMO2-modified PML. SUMO modifications of PML are also factors in the 291 
stability of PML proteins.  For example, arsenic trioxide triggers the loss of PML proteins by first 292 
inducing their hyperSUMOylation (Lallemand-Breitenbach et al. 2008; Lallemand-Breitenbach et al. 293 
2001; Tatham et al. 2008). Therefore the effect of RNF168 on PML SUMOylation may also be a 294 
factor in its ability to regulate the level of PML NBs.  295 
RNF168ΔMIU2 was found to localize to NBs formed by any single PML isoform. The PML 296 
isoforms are identical except for their C-terminal tails, which differ in length and sequence, and have 297 
been shown to mediate some isoform-specific interactions (Cuchet-Lourenco et al. 2012; 298 
Sivachandran et al. 2012b; Nisole et al. 2013).  The fact that RNF168 localization to PML NBs was 299 
not PML isoform-dependent indicates that recruitment of RNF168 to PML NBs involves the PML 300 
core sequences. These core sequences contain multiple SUMO interacting motifs (SIM) and SUMO 301 
modifications, and proteins that interact with PML core sequences typically do so through SUMO-302 
SIM interactions. This prompted us to examine whether RNF168 is SUMOylated or can bind 303 
SUMO-modified proteins (Fig. 8).  While RNF168 can be modified by SUMO1 in response to DNA 304 
damage (Danielsen et al. 2012), we did not detect any SUMO modifications of RNF168 under our 305 
conditions. Rather, RNF168 was found to bind high molecular weight complexes containing 306 
SUMO2 and SUMO3 chains. These interactions were dependent on the presence of the UMI /MIU1/ 307 
MIU2 ubiquitin interacting sequences suggesting, either that these sequences can also interact with 308 
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SUMO2/3 chains, or that the SUMO2/3 chains that were bound were hybrid chains that also 309 
contained ubiquitin.  310 
To clarify whether or not RNF168 can bind hybrid SUMO-ubiquitin chains, we conducted in 311 
vitro assays comparing recovery of RNF168 on resin containing chains of SUMO2, K63 ubiquitin or 312 
K63Ub-SUMO2 hybrids. We found that the hybrid chains were most efficiently bound by RNF168, 313 
whereas binding of purified RNF168 to SUMO2 chains was not detected (Fig. 8B, 8C and additional 314 
unpublished data). This suggests that the SUMO2/3-modified proteins that we recovered from cells 315 
contain hybrid SUMO-ubiquitin chains. This would explain the requirement for the ubiquitin-316 
binding sequences of RNF168 and suggests that RNF168 also contains a weak SIM. 317 
Taken together, our data suggest a model in which RNF168 is recruited to PML NBs through 318 
direct interaction with hybrid SUMO-ubiquitin chains which could be on PML proteins themselves 319 
or other PML-NB constituents, such as Daxx, Sp100 and BLM, which are also SUMO-modified 320 
(Seeler and Dejean 2001). In this respect, RNF168 may act downstream of RNF4, a SUMO-targeted 321 
ubiquitin ligase that generates hybrid chains and is known to negatively regulate PML NBs 322 
(Geoffroy and Hay 2009). Once recruited to PML NBs, RNF168 causes increased ubiquitylation and 323 
SUMOylation of PML proteins, which stimulates their proteasomal degradation.  It remains to be 324 
determined whether RNF 168 is recruited to PML NBs through interactions with hybrid SUMO-325 
ubiquitin chains on PML. Conducting experiments in cells expressing PML mutants lacking SUMO-326 
modified sites may be one way of clarifying whether SUMO or SUMO-ubiquitin chains on PML are 327 
required for RNF168 recruitment and induced ubiquitylation of PML. However, since the lack of 328 
SUMOylation of PML affects the structure and composition of the NBs (Lallemand-Breitenbach et 329 
al. 2001), any changes in RNF168 behaviour could not be conclusively attributed to a direct 330 
requirement for SUMO chains on PML. 331 
Our finding that RNF168 binds hybrid SUMO-ubiquitin chains is also likely to be relevant 332 
for RNF168 recruitment to sites of DNA damage. It has been previous reported that SUMO1, 333 
SUMO2 and SUMO3 accumulate at double stranded DNA breaks due to the action of PIAS4 and 334 
PIAS1, and that PIAS1/PIAS4 are needed for productive recruitment of RNF168 (Galanty et al. 335 
2009). We now suggest that this requirement may be due to the generation of hybrid SUMO-336 
ubiquitin chains, which are then recognized by RNF168. This would be similar to the recruitment of 337 
RAP80 to double-stranded DNA breaks, which has been shown to involve binding to SUMO-338 
ubiquitin hybrid chains generated by RNF4 (Hu et al. 2012; Guzzo et al. 2012).    339 
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Our studies have uncovered previously unrecognized roles for the RNF8 and RNF168 DNA 340 
damage response proteins in PML regulation. A relationship between DNA repair and PML NBs is 341 
well established, in that PML NBs are known to contribute to efficient DNA repair and have been 342 
shown to be associated with several DDR proteins (Bischof et al. 2001; Tikoo et al. 2013; Boichuk 343 
et al. 2011; Boe et al. 2006; Yeung et al. 2012; Zhong et al. 1999; Dellaire et al. 2006; Dellaire and 344 
Bazett-Jones 2004).  For example BLM localizes to PML NBs in cells with and without induced 345 
DNA damage, and PML is required for the formation of BLM-containing repair foci as well as for 346 
BLM function in DNA repair (Zhong et al. 1999; Bischof et al. 2001). However, others report a lack 347 
of association of PML with sites of active DNA repair (Dellaire et al. 2006), suggesting that the role 348 
of PML in DNA repair may be indirect, for example in facilitating modifications of DNA repair 349 
proteins (Lallemand-Breitenbach and de The 2010). Like BLM, we have shown that RNF168 350 
associates with PML NBs and that this interaction also occurs during the DDR.  Interestingly, 351 
RNF168 is modified by SUMO1 in response to DNA damage (Danielsen et al. 2012), and since 352 
PML NBs can promote SUMOylation, this might be one reason for the association of RNF168 with 353 
PML NBs. Whether or not the interaction of RNF168 with PML NBs is necessary for its function in 354 
the DDR or represents a distinct role of RNF168 in PML regulation remains to be determined.  355 
 356 
MATERIALS AND METHODS 357 
Cell lines 358 
 The EBV-negative NPC cell line CNE2Z (Sun et al. 1992) was maintained in alpha-MEM (Gibco) 359 
supplemented with 10% fetal bovine serum (FBS).  CNE2Z cell lines expressing single PML 360 
isoforms are described in Sarkari et al (Sarkari et al. 2011). U2OS cells were grown in Dulbecco’s 361 
modified essential medium (DMEM) supplemented with 10% FBS. 362 
 363 
shRNA screen 364 
CNE2Z cells were seeded in 384-well glass bottom plates (Perkin Elmer 6007550) in 50 µl media 365 
containing 8 μg/mL polybrene at a density of 500 cells/well. 1 hr later, 5 μl of shRNA-expressing 366 
lentivirus was added, corresponding to culture supernatant from a 96-well plate lentivirus infection. 367 
The lentivirus library targeted approximately 500 ubiquitin pathway proteins with 3 to 5 shRNA 368 
constructs per gene and is a subset of the library described in Moffat et al (Moffat et al. 2006). 369 
Infections with each lentivirus were set up in triplicate. 24 hrs later, 2 μg/ml puromycin was added to 370 
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select for the virus. The puromycin was removed 24 hours later and the cells were grown for 5 days 371 
before fixation and fluorescent staining for image acquisition. Cells were washed with PBS, fixed 372 
with 3.7% paraformaldehyde for 25 min, washed with PBS, permeabilized with PBS containing 1% 373 
Triton X-100 for 5 min, blocked with 4%BSA in PBS  for 2 hours and incubated with primary 374 
antibody solution (1:100 in 4% BSA in PBS) recognizing PML (Santa Cruz Biotechnology; sc-966) 375 
for 18 hours at 4oC. The cells were washed with PBS and incubated with blocking buffer containing 376 
1:700 dilution of goat anti-mouse conjugated Alexa Fluor 488 (Life Technologies;A11029) and 377 
1:1000 dilution of 10 mg/mL Hoechst (Molecular Probes).  After 1½ hours at room temperature in 378 
the dark, the cells were rinsed 3 times with PBS and stored in PBS.  Images from ten areas per well 379 
in the green (488) and blue (Hoechst) channels were obtained using a 40X objective on an Opera 380 
confocal microscope (PerkinElmer). The number and intensity of PML NBs was determined using 381 
Acapella software.   382 
 383 
Plasmids and siRNA 384 
  Plasmids expressing FLAG-tagged RNF8 (Genecopoeia), RNF168 (pcDNA3:FLAG-RNF168wt) 385 
or the RNF168 mutants ΔMIU1 (lacking amino acids 168-191), ΔMIU1 ΔMIU2 (lacking amino 386 
acids 168-191 and 439-462), ΔRING (lacking amino acids 1-58), ΔMIU2 (lacking amino acids 439-387 
462) were kindly supplied by Dan Durocher and are described in Stewart et al 2009. 388 
pcDNA3::FLAG ΔUMI ΔMIU1 ΔMIU2 (lacking amino acids 134-191 and 439-462) was generated 389 
by PCR amplification of the RNF168 sequences in pGFP-RNF168 ΔUMI ΔMIU1 ΔMIU2 (Panier et 390 
al. 2012) and insertion into Asc1 and Xba1 of pcDNA3:FLAG. Δ100-201ΔMIU2 was generated 391 
from pcDNA3::FLAG ΔMIU2 by Quik Change site directed mutagenesis. pEGFP:NLS-392 
RNF168aa100-201 was obtained from Dan Durocher and  is described in Panier et al (2012).  393 
pEGFP:NLS-RNF168 aa100-166 was generated by PCR amplification of the relevant RNF168 394 
sequences and ligation into Asc1 and Xba1 sites of pEGFP:NLS.  Stealth siRNA of RNF168 395 
(CCAUCCAGCCUCAUCUGGACCAGUU) and RNF8 396 
(GGGUUUGGAGAUAGCCCAAGGAGAA) were from Invitrogen.  AllStar negative-control 397 





  PML antibodies used for microscopy were from Santa Cruz Biotechnology (sc-966: 1:80 diltuion) 401 
and those used for Western blotting were from Bethyl (A301-167A; 1:2000 dilution). Other 402 
antibodies used were mouse anti-FLAG M2 (Sigma; 1:5000 dilution), rabbit anti-FLAG (Bethyl 403 
A190-102A; 1:5000 dilution), RNF 8 (Santa Cruz 271462; 1:200 dilution), RNF168 (Millipore 06-404 
1130; 1:1000 dilution), HA (Santa Cruz 7392; 1:500 dilution), K63-linked ubiquitin (Millipore 05-405 
1308; 1:1000 dilution), K48-linked ubiquitin (Millipore 05-1307; 1:10,000 dilution), myc (Santa 406 
Cruz 40; 1:500 dilution) and actin (Santa Cruz 1616; 1:2000 dilution). Secondary antibodies used for 407 
Western Blots (GAM/HRP -2055, GAR/HRP-2004; 1:5000 dilutions) were from Santa Cruz 408 
Biotechnology.  Secondary antibodies for microscopy were from Invitrogen (GAM488-A11029, 409 
GAM555, GAR488, GAR555; all at 1:700 dilution). 410 
 411 
Transfections 412 
 Approximately 6 x 105 CNE2Z cells were plated in 5 mls of medium in 10 cm dishes or on 413 
coverslips (for microscopy).  They were immediately transfected with 100 pmol of siRNA targeted 414 
against either RNF8 or RNF168 or AllStars negative control siRNA (Qiagen) using 2 µL of 415 
lipofectamine 2000 (Invitrogen).  The cells were subject to second and third rounds of the same 416 
transfection after 24 and 48 hours.  48 hours after the third round of transfections cells were 417 
harvested and either analyzed by Western blotting or processed for immunofluorescence 418 
microscopy. For overexpression experiments, cells plated as above were transfected with 2 μg of the 419 
indicated plasmid using PolyJet (FroggaBio) then harvested 24 hrs (for PML NB localization 420 
experiments) to 48 hrs (for PML loss experiments) post transfection. 421 
 422 
Immunofluorescence microscopy   423 
Cells grown on coverslips were fixed with 3.7% formaldehyde in PBS for 20 min, rinsed twice in 424 
PBS, and permeabilized with 1% Triton X-100 in PBS for 5 min. Samples were blocked with 4% 425 
bovine serum albumin (BSA) in PBS followed by incubation with primary antibodies as indicated, 426 
followed by secondary antibodies.  Coverslips were mounted on slides using ProLong Gold antifade 427 
medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Invitrogen). Images were obtained using 428 
the 40× oil objective on a Leica inverted fluorescence microscope and processed using the 429 
OpenLAB (ver.X.0) software program. PML was quantified by counting 100 cells per sample, and 430 
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experiments were performed in triplicate. Averages and standard deviations were calculated in 431 
Excel. P values were determined using two tailed t-tests in Excel. 432 
 433 
Western blotting 434 
 Cells were lysed in 9 M urea,10 mM Tris pH 6.8 followed by sonication.  50 µg of clarified lysates 435 
were loaded onto 10% SDS-PAGE and transferred onto nitrocellulose.  Membranes were blocked in 436 
5% non-fat dry milk in PBS-T (PBS with 0.1% Tween) for 1 hour, followed by incubation with 437 
primary antibody in blocking buffer overnight at room temperature. Membranes were washed three 438 
times with PBS-T and then incubated with secondary antibodies conjugated to horseradish 439 
peroxidase (Santa Cruz Biotechnology) for 1 hour.  Membranes were washed three times with PBS-440 
T and signals were detected by enhanced chemiluminescence (ECL) (Perkin Elmer Life and 441 
Analytical Sciences). 442 
 443 
PML ubiquitylation and SUMOylation assays 444 
For ubiquitylation assays, CNE2Z cells in a 15 cm dish were transfected with 5 µg of plasmid 445 
expressing HA-tagged ubiquitin and 5 μg of FLAG-RNF168 expression plasmid or empty control 446 
plasmid (pcDNA3) using Polyjet (FroggaBio Scientific Solutions). 40 hours post-transfection, cells 447 
were treated with 10 µM MG132 (Sigma) for 10 hours (except where indicated). Harvested cell 448 
pellets were frozen then thawed and boiled in 200 µl of SDS lysis buffer (62.5 mM Tris pH 6.8, 2% 449 
SDS, 10% glycerol, 1 mM N-ethyl maleimide). Clarified lysates were diluted with 1 ml IP buffer (50 450 
mM Tris pH 8.0, 150 mM NaCl, 1% NP-40).  Lysates were incubated overnight with PML antibody 451 
(Bethyl, A301-167A) and Protein A/G agarose (SantaCruz sc-2003). After washing in IP buffer, 452 
immunoprecipitates were eluted in loading buffer (60 mM Tris.HCl pH 6.8, 1% SDS, 100 mM DTT, 453 
5% glycerol) prior to western blotting. SUMOylation assays were performed as above except that 454 
the plasmid expressing HA-ubiquitin was replaced by myc-tagged SUMO2 (MacPherson et al. 2009) 455 
and no MG132 treatment was used.  A positive control for SUMOylation was also performed by 456 
treating pcDNA3/myc-SUMO2 transfected cells with 4 μM arsenic trioxide for 4 hrs. 457 
 458 
Cell-based assay for interaction of RNF168 with SUMO 459 
 293T cells were transfected with 10 µg of plasmid expressing myc-tagged SUMO1, SUMO2 or 460 
SUMO3 (MacPherson et al. 2009) (kindly supplied by Dr. Paul Sadowski) and 10 μg of FLAG-461 
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RNF168 expression plasmid or empty control plasmid (pcDNA3).  48 hrs later, cells were lysed 462 
in 50 mM Tris pH 7.4, 150 mM NaCl, 1% TritonX-100, 1 mM N-ethyl maleimide, P8340 463 
Protease Inhibitor (Sigma).  1.7 mg of lysate was incubated with 20 μl of M2 FLAG affinity 464 
resin (Sigma A2220) for 3 hours and then washed 4 times with 1 ml of lysis buffer.  Proteins 465 
were eluted in 2X SDS loading buffer (4% (w/v) SDS, 0.2% (w/v) bromophenol blue, 20% (v/v) 466 
glycerol, 200 mM DTT) then analysed by Western blotting. 467 
 468 
Generation of SUMO2/ubiquitin affinity resins  469 
4xSUMO2 (SUMO2 residues 2-92 linked to three copies of SUMO2 residues 12-92) and Ub-470 
4xSUMO2 were expressed and purified as described previously (Tatham et al. 2013). 471 
Unanchored K63-linked polyubiquitin chains (K63Ub), and K63-linked polyubiquitin chains 472 
conjugated to the N-terminus of 4xSUMO2 (K63Ub-4xSUMO2) were synthesized using 473 
recombinant Ubc13 and Ube2v2 as described previously (Branigan et al. 2015). These proteins 474 
were coupled to N-hydroxysuccinimide (NHS) resin in 0.2M NaHCO3, 0.5M NaCl as per 475 
manufacturer’s instructions (GE Healthcare). The remaining active groups were blocked with 476 
ethanolamine, and resins were stored at 4ºC. 477 
 478 
Identification of cellular proteins with affinity for SUMO2 and ubiquitin polymers. 479 
Nucelar extracts were generated from 293 N3S cells as previously described for U2OS cells 480 
(Seifert et al. 2015). Nuclear lysate (10 mls at 5.5 mg/ml) was incubated with 50 μl of the affinity 481 
resin overnight at 4°C with rotation, then resins were washed three times with RIPA buffer. 482 
Bound proteins were eluted by sequential incubation of the resins with 5 μM USP2 and 5 μM 483 
SENP1 for 2 hours at 22ºC, followed by a 5 minute incubation at 70ºC in denaturing buffer 484 
(Novex NuPAGE LDS sample buffer; Life technologies). SENP1 (415-644) was prepared as 485 
described previously (Shen et al. 2006a). 6His-USP2(259-605) was purified as described for 486 
RNF168 below. Since RNF168 was most abundant in the denaturing elutions, only these elutions 487 
were used in further analyses. Eluates were fractionated on a NuPAGE Novex 10% Bis-Tris gel 488 
run in MOPS buffer, followed by Coomassie staining. Each lane was cut into upper and lower 489 
portions, followed by peptide extraction and in gel tryptic digestion (Shevchenko et al. 2006). 490 
Extracted peptides were resuspended in 35μl 0.5% acetic acid, 0.1%TFA and 8 μl was analysed 491 
by LC-MS/MS on Q Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific). Data were 492 
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analysed with MaxQuant incorporating the Andromeda search engine (version 1.5.2.8) as in 493 
Tatham et al (Tatham et al. 2011). Protein intensity values based on extracted ion chromatograms 494 
(XICs) were reported for each purification. Protein intensities were arithmetically converted to 495 
ratio values and ratios were normalized to the median ratio of the entire group to allow for 496 
sample loading errors. Ratio scores were calculated for each protein by comparing data from 497 
each affinity resin to the blank resin. Only 69 proteins of the 1827 proteins processed had a ratio 498 
score >12 in at least one of the four comparisons. Hierarchical clustering was used to combine 499 
the four ratio scores of these proteins into a single heatmap using Perseus. 500 
 501 
Assay of purified RNF168 binding to SUMO2/ubiquitin polymers 502 
6His-RNF168 (full length) was expressed in E.coli and purified by nickel affinity 503 
chromatography, followed by removal of the 6His-tag by TEV protease digestion and 504 
repurification of the untagged product as previously described (Branigan et al. 2015). 10 μM 505 
purified RNF168 was incubated with 20 μl of each affinity resin in 100 μl of binding buffer (50 506 
mM Tris, 150 mM NaCl, 0.5 mM TCEP, 0.05% NP-40) overnight at 4°C.  Resins were collected 507 
by centrifugation at 500 x g for 1 minute, then washed twice with binding buffer. Bound proteins 508 
were eluted by sequential incubation with USP2, SENP1 and denaturing buffer as described 509 
above. Proteins from the denaturing elution were analysed by SDS-PAGE and Coomassie 510 
staining. 511 
 512 
 Acknowledgements 513 
We are grateful to Daniel Durocher for providing several constructs for RNF8 and RNF168 514 
expression and for helpful advice throughout the course of this work. We thank Patricia Mero and 515 
Cameron Landry for assistance in setting up the shRNA screen. We also thank Paul Sadowski and 516 
Melissa MacPherson for the plasmids expressing myc-tagged SUMO.   517 
 518 
Competing interests 519 
The authors declare no competing or financial interests. 520 
 521 
Author Contributions 522 
19 
 
L.F., K.S. and R.T.H. conceived of and designed the experiments. K.S., A.I.W., M.H.T., O.F.A., 523 
D.R. and S.G. performed the experiments. J.M. provided the lentivirus shRNA library and 524 




This work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to LF 529 
and by a Programme grant from Cancer Research UK to RTH. OFA was supported by a studentship 530 
from the Biotechnology and Biological Sciences Research Council. LF is a tier one Canada Research 531 
Chair. RTH is a Senior Investigator of the Wellcome Trust. 532 
 533 
  534 
20 
 
REFERENCES      535 
Ablain J, Rice K, Soilihi H, de Reynies A, Minucci S, De The H (2014). Activation of a 536 
promyelocytic leukemia–tumor protein 53 axis underlies acute promyelocytic leukemia 537 
cure. Nature Medicine 20,167-174 538 
Al-Hakim A, Escribano-Diaz C, Landry MC, O'Donnell L, Panier S, Szilard RK, Durocher 539 
D (2010). The ubiquitous role of ubiquitin in the DNA damage response. DNA Repair 540 
(Amst) 9 (12),1229-1240. doi,10.1016/j.dnarep.2010.09.011 541 
S1568-7864(10)00316-2 [pii] 542 
Bartocci C, Denchi EL (2013). Put a RING on it: regulation and inhibition of RNF8 and 543 
RNF168 RING finger E3 ligases at DNA damage sites. Front Genet 4,128. 544 
doi,10.3389/fgene.2013.00128 545 
Bernardi R, Pandolfi PP (2007). Structure, dynamics and functions of promyelocytic leukaemia 546 
nuclear bodies. Nat Rev Mol Cell Biol 8,1006-1016 547 
Bischof O, Kim SH, Irving J, Beresten S, Ellis NA, Campisi J (2001). Regulation and 548 
localization of the Bloom syndrome protein in response to DNA damage. J Cell Biol 153 549 
(2),367-380 550 
Boe SO, Haave M, Jul-Larsen A, Grudic A, Bjerkvig R, Lonning PE (2006). Promyelocytic 551 
leukemia nuclear bodies are predetermined processing sites for damaged DNA. J Cell Sci 552 
119 (Pt 16),3284-3295 553 
Boichuk S, Hu L, Makielski K, Pandolfi PP, Gjoerup OV (2011). Functional connection 554 
between Rad51 and PML in homology-directed repair. PLoS ONE 6 (10),e25814. 555 
doi,10.1371/journal.pone.0025814 556 
PONE-D-11-11910 [pii] 557 
Branigan E, Plechanovova A, Jaffray EG, Naismith JH, Hay RT (2015). Structural basis for 558 
the RING-catalyzed synthesis of K63-linked ubiquitin chains. Nat Struct Mol Biol 22 559 
(8),597-602. doi,10.1038/nsmb.3052 560 
nsmb.3052 [pii] 561 
Condemine W, Takahashi Y, Zhu J, Puvion-Dutilleul F, Guegan S, Janin A, de The H 562 
(2006). Characterization of endogenous human promyelocytic leukemia isoforms. Cancer 563 
Res 66 (12),6192-6198 564 
Cuchet-Lourenco D, Vanni E, Glass M, Orr A, Everett RD (2012). Herpes simplex virus 1 565 
ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent 566 
degradation. J Virol 86 (20),11209-11222. doi,JVI.01145-12 [pii] 567 
10.1128/JVI.01145-12 568 
Cuchet D, Sykes A, Nicolas A, Orr A, Murray J, Sirma H, Heeren J, Bartelt A, Everett RD 569 
(2011). PML isoforms I and II participate in PML-dependent restriction of HSV-1 570 
replication. J Cell Sci 124 (Pt 2),280-291. doi,jcs.075390 [pii] 571 
10.1242/jcs.075390 572 
Danielsen JR, Povlsen LK, Villumsen BH, Streicher W, Nilsson J, Wikstrom M, Bekker-573 
Jensen S, Mailand N (2012). DNA damage-inducible SUMOylation of HERC2 574 
promotes RNF8 binding via a novel SUMO-binding Zinc finger. J Cell Biol 197 (2),179-575 
187. doi,10.1083/jcb.201106152 576 
jcb.201106152 [pii] 577 
de The H, Le Bras M, Lallemand-Breitenbach V (2012). The cell biology of disease: Acute 578 




jcb.201112044 [pii] 581 
Dellaire G, Bazett-Jones DP (2004). PML nuclear bodies: dynamic sensors of DNA damage 582 
and cellular stress. Bioessays 26 (9),963-977 583 
Dellaire G, Ching RW, Ahmed K, Jalali F, Tse KC, Bristow RG, Bazett-Jones DP (2006). 584 
Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response 585 
to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and 586 
ATR. J Cell Biol 175 (1),55-66 587 
Doil C, Mailand N, Bekker-Jensen S, Menard P, Larsen DH, Pepperkok R, Ellenberg J, 588 
Panier S, Durocher D, Bartek J, Lukas J, Lukas C (2009). RNF168 binds and 589 
amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair 590 
proteins. Cell 136 (3),435-446. doi,10.1016/j.cell.2008.12.041 591 
S0092-8674(09)00004-X [pii] 592 
Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L (2013). Arkadia, a novel 593 
SUMO-targeted ubiquitin ligase involved in PML degradation. Mol Cell Biol 33 594 
(11),2163-2177. doi,10.1128/MCB.01019-12 595 
MCB.01019-12 [pii] 596 
Everett RD, Chelbi-Alix MK (2007). PML and PML nuclear bodies: implications in antiviral 597 
defence. Biochimie 89 (6-7),819-830 598 
Fanelli M, Fantozzi A, De Luca P, Caprodossi S, Matsuzawa S, Lazar MA, Pelicci PG, 599 
Minucci S (2004). The coiled-coil domain is the structural determinant for mammalian 600 
homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein 601 
and other tripartite motif proteins by the proteasome. J Biol Chem 279 (7),5374-5379. 602 
doi,10.1074/jbc.M306407200 603 
M306407200 [pii] 604 
Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP (2009). 605 
Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-606 
strand breaks. Nature 462 (7275),935-939. doi,10.1038/nature08657 607 
nature08657 [pii] 608 
Geoffroy MC, Chelbi-Alix MK (2011). Role of promyelocytic leukemia protein in host 609 
antiviral defense. J Interferon Cytokine Res 31 (1),145-158. doi,10.1089/jir.2010.0111 610 
Geoffroy MC, Hay RT (2009). An additional role for SUMO in ubiquitin-mediated proteolysis. 611 
Nat Rev Mol Cell Biol 10 (8),564-568. doi,10.1038/nrm2707 612 
nrm2707 [pii] 613 
Guzzo CM, Berndsen CE, Zhu J, Gupta V, Datta A, Greenberg RA, Wolberger C, Matunis 614 
MJ (2012). RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and 615 
thereby mediate the recruitment of BRCA1 to sites of DNA damage. Sci Signal 5 616 
(253),ra88. doi,10.1126/scisignal.2003485 617 
5/253/ra88 [pii] 618 
Hu X, Paul A, Wang B (2012). Rap80 protein recruitment to DNA double-strand breaks 619 
requires binding to both small ubiquitin-like modifier (SUMO) and ubiquitin conjugates. 620 
J Biol Chem 287 (30),25510-25519. doi,10.1074/jbc.M112.374116 621 
M112.374116 [pii] 622 
Lallemand-Breitenbach V, de The H (2010). PML nuclear bodies. Cold Spring Harb Perspect 623 
Biol 2 (5),a000661 624 
22 
 
Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, 625 
Raught B, de The H (2008). Arsenic degrades PML or PML-RARalpha through a 626 
SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 10 (5),547-555 627 
Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honore N, Doubeikovsky A, Duprez 628 
E, Pandolfi PP, Puvion E, Freemont P, de The H (2001). Role of promyelocytic 629 
leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and 630 
As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med 193 631 
(12),1361-1371 632 
MacPherson MJ, Beatty LG, Zhou W, Du M, Sadowski PD (2009). The CTCF insulator 633 
protein is posttranslationally modified by SUMO. Mol Cell Biol 29 (3),714-725. 634 
doi,10.1128/MCB.00825-08 635 
MCB.00825-08 [pii] 636 
Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J (2007). 637 
RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of 638 
repair proteins. Cell 131 (5),887-900. doi,S0092-8674(07)01271-8 [pii] 639 
10.1016/j.cell.2007.09.040 640 
Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure 641 
TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, 642 
Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE (2006). A lentiviral RNAi 643 
library for human and mouse genes applied to an arrayed viral high-content screen. Cell 644 
124 (6),1283-1298. doi,S0092-8674(06)00238-8 [pii] 645 
10.1016/j.cell.2006.01.040 646 
Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK (2013). Differential Roles of 647 
PML Isoforms. Front Oncol 3,125. doi,10.3389/fonc.2013.00125 648 
Panier S, Durocher D (2009). Regulatory ubiquitylation in response to DNA double-strand 649 
breaks. DNA Repair (Amst) 8 (4),436-443. doi,S1568-7864(09)00008-1 [pii] 650 
10.1016/j.dnarep.2009.01.013 651 
Panier S, Ichijima Y, Fradet-Turcotte A, Leung CC, Kaustov L, Arrowsmith CH, 652 
Durocher D (2012). Tandem protein interaction modules organize the ubiquitin-653 
dependent response to DNA double-strand breaks. Mol Cell 47 (3),383-395. 654 
doi,10.1016/j.molcel.2012.05.045 655 
S1097-2765(12)00490-X [pii] 656 
Pinato S, Scandiuzzi C, Arnaudo N, Citterio E, Gaudino G, Penengo L (2009). RNF168, a 657 
new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of 658 
histones H2A and H2AX. BMC Mol Biol 10,55. doi,10.1186/1471-2199-10-55 659 
1471-2199-10-55 [pii] 660 
Rabellino A, Scaglioni PP (2013). PML Degradation: Multiple Ways to Eliminate PML. Front 661 
Oncol 3,60. doi,10.3389/fonc.2013.00060 662 
Salomoni P, Ferguson BJ, Wyllie AH, Rich T (2008). New insights into the role of PML in 663 
tumour suppression. Cell Res 18 (6),622-640 664 
Sarkari F, Wang X, Nguyen T, Frappier L (2011). The herpesvirus associated ubiquitin 665 
specific protease, USP7, is a negative regulator of PML proteins and PML nuclear 666 
bodies. PLoS ONE 6 (1),e16598. doi,10.1371/journal.pone.0016598 667 
Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B, Teruya-668 
Feldstein J, Tempst P, Pandolfi PP (2006). A CK2-dependent mechanism for 669 
degradation of the PML tumor suppressor. Cell 126 (2),269-283 670 
23 
 
Scaglioni PP, Yung TM, Choi SC, Baldini C, Konstantinidou G, Pandolfi PP (2008). CK2 671 
mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor 672 
suppressor. Mol Cell Biochem 316,149-154 673 
Seeler JS, Dejean A (2001). SUMO: of branched proteins and nuclear bodies. Oncogene 20 674 
(49),7243-7249. doi,10.1038/sj.onc.1204758 675 
Seifert A, Schofield P, Barton GJ, Hay RT (2015). Proteotoxic stress reprograms the 676 
chromatin landscape of SUMO modification. Sci Signal 8 (384),rs7. 677 
doi,10.1126/scisignal.aaa2213 678 
8/384/rs7 [pii] 679 
Shen L, Tatham MH, Dong C, Zagorska A, Naismith JH, Hay RT (2006a). SUMO protease 680 
SENP1 induces isomerization of the scissile peptide bond. Nat Struct Mol Biol 13 681 
(12),1069-1077. doi,nsmb1172 [pii] 682 
10.1038/nsmb1172 683 
Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006b). The mechanisms of PML-684 
nuclear body formation. Mol Cell 24 (3),331-339 685 
Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M (2006). In-gel digestion for mass 686 
spectrometric characterization of proteins and proteomes. Nat Protoc 1 (6),2856-2860. 687 
doi,nprot.2006.468 [pii] 688 
10.1038/nprot.2006.468 689 
Sivachandran N, Cao JY, Frappier L (2010). Epstein-Barr virus nuclear antigen 1 Hijacks the 690 
host kinase CK2 to disrupt PML nuclear bodies. J Virol 84 (21),11113-11123 691 
Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L (2012a). 692 
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol 86 693 
(1),60-68. doi,JVI.05623-11 [pii] 694 
10.1128/JVI.05623-11 695 
Sivachandran N, Sarkari F, Frappier L (2008). Epstein-Barr nuclear antigen 1 contributes to 696 
nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog 4 697 
(10),e1000170. doi,10.1371/journal.ppat.1000170 698 
Sivachandran N, Wang X, Frappier L (2012b). Functions of the Epstein-Barr Virus EBNA1 699 
Protein in Viral Reactivation and Lytic Infection. J Virol 86 (11),6146-6158. 700 
doi,JVI.00013-12 [pii] 701 
10.1128/JVI.00013-12 702 
Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, Nakada S, 703 
Ylanko J, Olivarius S, Mendez M, Oldreive C, Wildenhain J, Tagliaferro A, 704 
Pelletier L, Taubenheim N, Durandy A, Byrd PJ, Stankovic T, Taylor AM, 705 
Durocher D (2009). The RIDDLE syndrome protein mediates a ubiquitin-dependent 706 
signaling cascade at sites of DNA damage. Cell 136 (3),420-434. doi,S0092-707 
8674(09)00005-1 [pii] 708 
10.1016/j.cell.2008.12.042 709 
Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y, Yao KT, 710 
Colburn NH (1992). An infrequent point mutation of the p53 gene in human 711 
nasopharyngeal carcinoma. Proc Natl Acad Sci U S A 89 (14),6516-6520 712 
Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo 713 
JJ, Hay RT (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for 714 
arsenic-induced PML degradation. Nat Cell Biol 10 (5),538-546 715 
24 
 
Tatham MH, Matic I, Mann M, Hay RT (2011). Comparative proteomic analysis identifies a 716 
role for SUMO in protein quality control. Sci Signal 4 (178),rs4. 717 
doi,10.1126/scisignal.2001484 718 
4/178/rs4 [pii] 719 
Tatham MH, Plechanovova A, Jaffray EG, Salmen H, Hay RT (2013). Ube2W conjugates 720 
ubiquitin to alpha-amino groups of protein N-termini. Biochem J 453 (1),137-145. 721 
doi,10.1042/BJ20130244 722 
BJ20130244 [pii] 723 
Tavalai N, Stamminger T (2009). Interplay between Herpesvirus Infection and Host Defense 724 
by PML Nuclear Bodies. Viruses 1 (3),1240-1264. doi,10.3390/v1031240 725 
viruses-01-01240 [pii] 726 
Tavalai N, Stamminger T (2011). Intrinsic cellular defense mechanisms targeting human 727 
cytomegalovirus. Virus Res 157 (2),128-133. doi,S0168-1702(10)00361-8 [pii] 728 
10.1016/j.virusres.2010.10.002 729 
Tikoo S, Madhavan V, Hussain M, Miller ES, Arora P, Zlatanou A, Modi P, Townsend K, 730 
Stewart GS, Sengupta S (2013). Ubiquitin-dependent recruitment of the Bloom 731 
syndrome helicase upon replication stress is required to suppress homologous 732 
recombination. Embo J 32 (12),1778-1792. doi,10.1038/emboj.2013.117 733 
emboj2013117 [pii] 734 
Wolyniec K, Shortt J, de Stanchina E, Levav-Cohen Y, Alsheich-Bartok O, Louria-Hayon 735 
I, Corneille V, Kumar B, Woods SJ, Opat S, Johnstone RW, Scott CL, Segal D, 736 
Pandolfi PP, Fox S, Strasser A, Jiang YH, Lowe SW, Haupt S, Haupt Y (2012). 737 
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven 738 
lymphomagenesis. Blood 120 (4),822-832. doi,10.1182/blood-2011-10-387647 739 
blood-2011-10-387647 [pii] 740 
Wu HC, Lin YC, Liu CH, Chung HC, Wang YT, Lin YW, Ma HI, Tu PH, Lawler SE, 741 
Chen RH (2014). USP11 regulates PML stability to control Notch-induced malignancy 742 
in brain tumours. Nat Commun 5,3214. doi,10.1038/ncomms4214 743 
ncomms4214 [pii] 744 
Yeung PL, Denissova NG, Nasello C, Hakhverdyan Z, Chen JD, Brenneman MA (2012). 745 
Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break 746 
repair by homologous recombination. J Cell Biochem 113 (5),1787-1799. 747 
doi,10.1002/jcb.24050 748 
Yuan WC, Lee YR, Huang SF, Lin YM, Chen TY, Chung HC, Tsai CH, Chen HY, Chiang 749 
CT, Lai CK, Lu LT, Chen CH, Gu DL, Pu YS, Jou YS, Lu KP, Hsiao PW, Shih 750 
HM, Chen RH (2011). A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets 751 
PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell 20 752 
(2),214-228. doi,10.1016/j.ccr.2011.07.008 753 
S1535-6108(11)00263-7 [pii] 754 
Zhong S, Hu P, Ye TZ, Stan R, Ellis NA, Pandolfi PP (1999). A role for PML and the nuclear 755 




  760 
25 
 
FIGURE LEGENDS 761 
Fig. 1.  An shRNA screen identifies RNF8 and RNF168 as regulators of PML NBs. CNE2Z cells 762 
were infected with a lentivirus expressing an shRNA targeted to RNF111 (negative control), 763 
RNF168 (shRNAs 1 to 5) or RNF8 (shRNAs 1 to 5) or left uninfected (none).  Cells were then fixed, 764 
stained with Hoechst and with PML-specific antibody, then imaged by confocal microscopy. A. The 765 
number of PML NBs per cell and intensity of PML NBs was determined. Average values with 766 
standard deviation are shown. B. Sample images for the indicated shRNAs from A.  767 
 768 
Fig. 2.  siRNA targeting RNF8 and RNF168 increases PML NBs and PML protein levels. A. 769 
CNE2Z cells were transfected with siRNA targeting RNF8 or RNF168 or negative control siRNA 770 
(control), then stained for PML. B. The number of PML NBs per cell was determined for 100 cells 771 
in 3 independent experiments and average values with standard deviation were plotted.  P values 772 
(determined by t-tests) are indicated as follows: * = 0.01<P < 0.05; ** = 0.001<P < 0.01; *** = P < 773 
0.001.  C. CNE2Z cells treated with siRNA as in A were lysed and analysed by Western blotting 774 
using the indicated antibodies. PML bands were quantified by densitometry and normalized to actin, 775 
and values for each lane are shown relative to the Control lane under the gel. D to F. The same 776 
experiment as in A to C but performed in U2OS cells. 777 
 778 
Fig. 3.  Overexpression of RNF8 or RNF 168 induces loss of PML NBs. A. CNE2Z cells were 779 
transfected with plasmids expressing FLAG-tagged RNF8 or RNF168 then stained for FLAG and 780 
PML. Sample images showing fewer PML NBs in FLAG-positive cells are shown. B. PML NBs 781 
were counted for cells expressing FLAG-RNF8 or FLAG-RNF168 and compared to cells transfected 782 
with empty plasmid (pcDNA3). Average values with standard deviation are shown from 3 783 
independent experiments, with P values defined as in Fig. 2.   784 
 785 
Fig. 4.  RNF168 can induce loss of PML NBs independent of RNF8. CNE2Z cells were treated with 786 
siRNA targeting RNF8 (siRNF8) or negative control siRNA (control) then transfected with the 787 
FLAG-RNF168 expression plasmid (bottom two rows in A) or empty control plasmid pcDNA3 (top 788 
two rows in A). Cells were then either fixed and stained for PML and FLAG (A) or lysed and 789 
analysed by Western blotting using RNF8 specific antibody to confirm RNF8 silencing (B). C. PML 790 
NBs in A were counted for 100 cells in three independent experiments. For RNF168 samples, PML 791 
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NBs were counted only in FLAG-positive cells. Average values with standard deviations are plotted 792 
with  P values (*** = P < 0.001) for RNF168 overexpression shown relative to the pcDNA3 control 793 
in each condition. 794 
 795 
Fig. 5.  RNF168 localization to PML NBs. A. Schematic representation of RNF168 showing the 796 
positions of the catalytic RING domain, ubiquitin binding sequences (UMI, MIU1, MIU2) and LR 797 
motifs (LRM) (Panier et al. 2012).  B. CNE2Z cells were transiently transfected with plasmids 798 
expressing FLAG-tagged RNF168 with WT sequence or the indicated deletions or with pcDNA3 799 
empty plasmid.  Cells were then stained for FLAG and PML and imaged by fluorescence 800 
microscopy. C. Western blots for FLAG-tagged and GFP-tagged proteins expressed in B and D. D. 801 
CNE2Z cells were transfected with plasmids expressing GFP fused to RNF168 amino acids 100-201 802 
(containing LRM1, UMI and MIU1) or 100-166 (containing LRM1 and UMI) or GFP alone, then 803 
stained for PML and imaged for GFP and PML. E. In the bottom panels, CNE2Z cells were 804 
transiently transfected with plasmids expressing FLAG-ΔRING, treated with etoposide (10 μg/ml) 805 
for 5 hours then stained for FLAG and PML and imaged by fluorescence microscopy. In the top 806 
panels, CNE2Z cells were treated with etoposide as in bottom panels or left untreated as indicated, 807 
then stained for 53BP1 to confirm that DDR foci were induced by etoposide.  808 
 809 
Fig. 6.  RNF168 localizes to NBs formed by any PML isoform. A plasmid expressing FLAG-tagged 810 
RNF168 ΔMIU2 was used to transfect CNE2Z cells or CNE2Z cells that lack WT PML but express 811 
a single recombinant PML isoform ( PML I to PML VI) (Sarkari et al. 2011; Sivachandran et al. 812 
2012b). Cells were then stained for FLAG and PML. 813 
 814 
Fig. 7.  RNF168 induces PML ubiquitylation and SUMOylation. A. CNE2Z cells were transfected 815 
with a plasmid expressing HA-tagged ubiquitin and a second plasmid expressing RNF168 or the 816 
RNF168 mutants ΔMIU2, ΔUb (ΔUMIΔMIU1ΔMIU2) or ΔRING or empty plasmid (pcDNA3) in 817 
the presence of proteasomal inhibition.  Total PML was then immunoprecipitated from cell lysates 818 
and analysed by Western blotting for PML and HA (IP).  A sample of the cell lysate prior to 819 
immunoprecipitation is also shown (INPUT).  B. Experiments were performed as in A in either the 820 
presence (+) or absence (-) of MG132 proteasomal inhibitor.  Ubiquitylated proteins in input and IP 821 
samples were detected by Western blotting using antibodies against HA, K48-linked ubiquitin or 822 
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K63-linked ubiquitin.  C.  The same experiments as in A except that the plasmid expressing HA-823 
tagged ubiquitin was replaced by one expressing myc-tagged SUMO2. In addition, a positive control 824 
for PML SUMOylation is shown, in which cells transfected with pcDNA3 were treated with arsenic 825 
trioxide (pcDNA3+As). Two exposures of the Input FLAG blot are shown. 826 
 827 
Fig. 8.  RNF168 associates with SUMO2/3-modified proteins in cells and preferentially binds 828 
hybrid ubiquitin-SUMO chains in vitro.  A. 293T cells were co-transfected with a plasmid 829 
expressing FLAG-tagged RNF168 (wt), RNF168ΔUb (ΔUMIΔMIU1ΔMIU2) or empty plasmid 830 
(Control) and a second plasmid expressing myc-tagged SUMO1, SUMO2 or SUMO3. After cell 831 
lysis, a sample was analysed by Western blotting (Input), while the remaining sample was 832 
subjected to FLAG IP, followed by Western blotting for Myc and FLAG. The positions of 833 
molecular weight markers are indicated on the right. B. Comparison of retention of RNF168 834 
from 293 cell extracts on affinity resins containing K63-ubiquitin polymers (K63-Ub), a linear 835 
4xSUMO2 chain (4xSUMO-2), an N-terminally monoubiquitinated 4xSUMO2 chain (Ub-836 
4xSUMO-2), hybrid chains containing K63-ubiquitin polymers linked to 4xSUMO-2 (K63Ub-837 
4xSUMO-2) or no protein (blank). Total intensity of RNF168 peptides retained on each resin are 838 
shown. RNF168 identification was based on 26 unique peptides, 47% sequence coverage. C. 839 
Purified RNF168 was incubated with the affinity resins or blank resin from B and, after washing 840 
was eluted with denaturing buffer. A Coomassie stained gel is shown of the protein loaded onto 841 
the resins (load) and eluted from the indicated resins (Pulldown).   842 
 843 
 844 








